Logo image of SAMA

SCHULTZE SPECIAL PURPOSE-A (SAMA) Stock Fundamental Analysis

NASDAQ:SAMA - Nasdaq - US8082121042 - Common Stock - Currency: USD

10.58  0 (0%)

Fundamental Rating

2

Overall SAMA gets a fundamental rating of 2 out of 10. We evaluated SAMA against 0 industry peers in the Unkown industry. While SAMA seems to be doing ok healthwise, there are quite some concerns on its profitability. SAMA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year SAMA was profitable.
SAMA had a negative operating cash flow in the past year.
SAMA Yearly Net Income VS EBIT VS OCF VS FCFSAMA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2021 2022 -1M -2M -3M

1.2 Ratios

Industry RankSector Rank
ROA 4.53%
ROE 5.75%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SAMA Yearly ROA, ROE, ROICSAMA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2021 2022 -0.5 -1

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for SAMA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SAMA Yearly Profit, Operating, Gross MarginsSAMA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2021 2022

More info and screens

5

2. Health

2.1 Basic Checks

The number of shares outstanding for SAMA remains at a similar level compared to 1 year ago.
There is no outstanding debt for SAMA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
SAMA Yearly Shares OutstandingSAMA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2021 2022 5M 10M 15M 20M
SAMA Yearly Total Debt VS Total AssetsSAMA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2021 2022 50M 100M 150M

2.2 Solvency

An Altman-Z score of 7.09 indicates that SAMA is not in any danger for bankruptcy at the moment.
SAMA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 7.09
ROIC/WACCN/A
WACCN/A
SAMA Yearly LT Debt VS Equity VS FCFSAMA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2021 2022 0 50M 100M 150M

2.3 Liquidity

SAMA has a Current Ratio of 0.13. This is a bad value and indicates that SAMA is not financially healthy enough and could expect problems in meeting its short term obligations.
SAMA has a Quick Ratio of 0.13. This is a bad value and indicates that SAMA is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.13
Quick Ratio 0.13
SAMA Yearly Current Assets VS Current LiabilitesSAMA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2021 2022 500K 1M 1.5M 2M

More info and screens

1

3. Growth

3.1 Past

SAMA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 198.95%, which is quite impressive.
EPS 1Y (TTM)198.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%147.6%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 81.38, SAMA can be considered very expensive at the moment.
When comparing the Price/Earnings ratio of SAMA to the average of the S&P500 Index (27.21), we can say SAMA is valued expensively.
Industry RankSector Rank
PE 81.38
Fwd PE N/A
SAMA Price Earnings VS Forward Price EarningsSAMA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SAMA Per share dataSAMA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SAMA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SCHULTZE SPECIAL PURPOSE-A

NASDAQ:SAMA (10/11/2023, 8:00:01 PM)

10.58

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners2.09%
Inst Owner Change0%
Ins Owners43.07%
Ins Owner Change0%
Market Cap139.34M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 81.38
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 3.39
P/tB 3.39
EV/EBITDA N/A
EPS(TTM)0.13
EY1.23%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS0
BVpS3.12
TBVpS3.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.53%
ROE 5.75%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.13
Quick Ratio 0.13
Altman-Z 7.09
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)198.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%147.6%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y49.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-51.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-51.08%
OCF growth 3YN/A
OCF growth 5YN/A